Rare Disease Genetic Testing Market Report 2022: Increased Number of Patients Undergoing Testing Presents Opportunities
November 30, 2022 04:03 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; By Technology; By Disease Type; By End-Use; By Region;...
Global Epigenetics (Reagents, Enzymes, Instruments, Kits) Market Research Report 2022: A $14.79 Billion Market in 2026 - Long-term Forecasts to 2031
November 22, 2022 06:05 ET
|
Research and Markets
Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global epigenetics market is expected to grow...
Myriad Genetics Focuses on Expanding Access, Collaboration and Equity in Genetic Testing at National Society of Genetic Counselors Meeting
November 14, 2022 08:00 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will spotlight efforts to expand access to prenatal and...
Global Pharmacogenomics Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray
November 11, 2022 06:28 ET
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global pharmacogenomics market is expected...
Cannabis Testing Market Size to Grow Nearly 3 Bn by 2028 with a CAGR of 10.1% - Exclusive Report by The Insight Partners
November 09, 2022 07:08 ET
|
The Insight Partners
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new research study titled "Cannabis Testing Market Size, Share, Growth and Forecast to 2028 – COVID-19 Impact and Global...
Global Prenatal Genetic Testing Market Report 2022-2026: Technological Advancement and Low-Cost Solutions Present Opportunities
November 07, 2022 04:35 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Prenatal Genetic Testing - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. New technological advances in...
GoodCell Adds HSA Bank to its Network, Expanding the Company’s Targeted Reach to HSA & FSA Account Holders
November 02, 2022 07:30 ET
|
GoodCell
Norwalk, CT, Nov. 02, 2022 (GLOBE NEWSWIRE) -- GoodCell, a life sciences company, added HSA Bank, a division of Webster Bank, N.A., to its growing network comprised of benefits administrators,...
Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies
October 31, 2022 09:00 ET
|
Sema4
STAMFORD, Conn., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, supports the new National Society of Genetic Counselors guidelines recommending exome...
Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns
October 27, 2022 08:00 ET
|
Sema4
-- Abnormal findings reported in 63% of infants in study, change in health management recommended in 88% of cases ---- Sema4|GeneDx contributes to latest data in the SeqFirst study being presented at...
Global Gene Panel Market Size & Share to Surpass $3.09 Bn by 2028| Vantage Market Research
October 26, 2022 09:02 ET
|
Vantage Market Research
WASHINGTON, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research analyses that the Gene Panel Market which was USD 2.20 Billion in 2021, would rocket up to USD 3.09 Billion by 2028, and is...